Chou CY - Search Results

1

Cell fate regulation by gelsolin in human gynecologic cancers.

Abedini MR, Wang PW, Huang YF, Cao M, Chou CY, Shieh DB, Tsang BK. Abedini MR, et al. Among authors: chou cy. Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14442-7. doi: 10.1073/pnas.1401166111. Epub 2014 Sep 22. Proc Natl Acad Sci U S A. 2014. PMID: 25246592 Free PMC article.

2

Three-dimensional power doppler ultrasound is useful to monitor the response to treatment in a patient with primary papillary serous carcinoma of the peritoneum.

Su JM, Huang YF, Chen HH, Cheng YM, Chou CY. Su JM, et al. Among authors: chou cy. Ultrasound Med Biol. 2006 May;32(5):623-6. doi: 10.1016/j.ultrasmedbio.2006.01.005. Ultrasound Med Biol. 2006. PMID: 16677920

3

EGF upregulates Na+/H+ exchanger NHE1 by post-translational regulation that is important for cervical cancer cell invasiveness.

Chiang Y, Chou CY, Hsu KF, Huang YF, Shen MR. Chiang Y, et al. Among authors: chou cy. J Cell Physiol. 2008 Mar;214(3):810-9. doi: 10.1002/jcp.21277. J Cell Physiol. 2008. PMID: 17894388

4

Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis.

Chen YF, Chiu WT, Chen YT, Lin PY, Huang HJ, Chou CY, Chang HC, Tang MJ, Shen MR. Chen YF, et al. Among authors: chou cy. Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15225-30. doi: 10.1073/pnas.1103315108. Epub 2011 Aug 29. Proc Natl Acad Sci U S A. 2011. PMID: 21876174 Free PMC article.

5

Brain metastases from epithelial ovarian carcinoma: evaluation of prognosis and managements - a Taiwanese Gynecologic Oncology Group (TGOG) study.

Chiang YC, Qiu JT, Chang CL, Wang PH, Ho CM, Lin WC, Huang YF, Lin H, Lu CH, Chou CY. Chiang YC, et al. Among authors: chou cy. Gynecol Oncol. 2012 Apr;125(1):37-41. doi: 10.1016/j.ygyno.2011.12.438. Epub 2011 Dec 22. Gynecol Oncol. 2012. PMID: 22198245

6

Circulating IGF system and treatment outcome in epithelial ovarian cancer.

Huang YF, Cheng WF, Wu YP, Cheng YM, Hsu KF, Chou CY. Huang YF, et al. Among authors: chou cy. Endocr Relat Cancer. 2014 Jan 30;21(2):217-29. doi: 10.1530/ERC-13-0274. Print 2014 Apr. Endocr Relat Cancer. 2014. PMID: 24273235

7

Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: a Taiwanese Gynecologic Oncology Group study.

Chen CA, Lin H, Weng CS, Wen KC, Lu CH, Chou HH, Huang YF, Kang CY, Ho CM, Yu MH, Chou CY. Chen CA, et al. Among authors: chou hh, chou cy. Eur J Cancer. 2014 Dec;50(18):3161-7. doi: 10.1016/j.ejca.2014.10.006. Eur J Cancer. 2014. PMID: 25459394

8

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.

Chiu WT, Huang YF, Tsai HY, Chen CC, Chang CH, Huang SC, Hsu KF, Chou CY. Chiu WT, et al. Among authors: chou cy. Oncotarget. 2015 Feb 10;6(4):2349-65. doi: 10.18632/oncotarget.2957. Oncotarget. 2015. PMID: 25537512 Free PMC article.

9

All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells.

Young MJ, Wu YH, Chiu WT, Weng TY, Huang YF, Chou CY. Young MJ, et al. Among authors: chou cy. Carcinogenesis. 2015 Apr;36(4):498-507. doi: 10.1093/carcin/bgv018. Epub 2015 Mar 5. Carcinogenesis. 2015. PMID: 25742746

10

COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization.

Wu YH, Chang TH, Huang YF, Chen CC, Chou CY. Wu YH, et al. Among authors: chou cy. Oncotarget. 2015 Sep 15;6(27):23748-63. doi: 10.18632/oncotarget.4250. Oncotarget. 2015. PMID: 26087191 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

618 results

Search Page

Filters